INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN

The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atroph...

Full description

Saved in:
Bibliographic Details
Main Authors MØLLER, NIELS, CHRISTENSEN, BRITT, JÆGER, TANJA CHRISTINE, MOSE, MAIKE, FREDERIKSEN, PERNILLE DORTHEA, LAURIDSEN, KASPER BØGELUND, MIKKELSEN, ULLA RAMER, NIELSEN, SØREN BANG, SMEDEGAARD, STINE BECH, HULMAN, ADAM, RITTIG, NIKOLAJ FIBIGER, MARKHOLM, MIE
Format Patent
LanguageEnglish
Polish
Published 20.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
Bibliography:Application Number: PL20200808127T